Document Detail

Phenotypic subgroups of polycystic ovary syndrome have different intra-renal resistance symptoms.
MedLine Citation:
PMID:  23488293     Owner:  NLM     Status:  In-Process    
OBJECTIVE: The polycystic ovary syndrome (PCOS) is known to be related with increased metabolic and cardiovascular risks. Various phenotypic subgroups of PCOS have been proven to have metabolic and endocrine disorders with varying degrees of severity However, intra-renal vascular resistance, which is an indirect indication of atherosclerosis, remains unknown in PCOS subgroups. In this study we examined whether PCOS subgroups have different intra-renal resistance symptoms.
MATERIAL AND METHODS: 98 PCOS patients (diagnosed according to the Rotterdam criteria) 30 controls were included in the study The diagnosis of PCOS was established in the presence of at least two of the following criteria: 1-oligo and/or amenorrhea (OM); 2-clinic and/or biochemical signs of hyperandrogenism (HA); 3-polycystic ovarian morphology (PCO) detected by transvaginal ultrasonography 37 patients (Group 1) met all three criteria (HA+OM+PCO), 29 patients (Group 2) met two of the criteria including hyperandrogenism (HA+OM or HA+PCO) and the remaining 32 patients (Group 3) had no hyperandrogenism but fulfilled the other two criteria; PCO+OM. Renal Doppler ultrasonography and hormonal/biochemical analyses were carried out. The first outcome measure was designated as the differences in the renal resistive index (RRI) values of the groups, and the second outcome measure was designated as the relation of RRI with the insulin resistance and lipid profile.
RESULTS: In Group 1, the RRI and the homeostasis model assessment of insulin resistance (HOMA-IR) values were significantly higher than in Group 3 and controls (P < 0.031, P < 0.001, respectively after adjusting for age and BMI). The RRI and HOMA-IR values in Group 3 were similar to those of the control group. It was determined that RRI has a positive correlation with HOMA-IR (r = 0.784, P < .0001) and BMI (r = 0.645, P < .0001).
CONCLUSIONS: In this study we demonstrated that PCOS subgroups have metabolic and endocrine disorders and cardiovascular risks of varying degrees of severity Moreover, we showed that there was no increase of metabolic and cardiovascular risks in PCOS patients without hyperandrogenism.
Ceylan F Ciftci; Ayla Uckuyu; Elif Karadeli; Erdem Turhan; Erzat Toprak; Emel E Ozcimen
Related Documents :
23244913 - 79 a combination of ethylene glycol and propylene glycol is superior to individual cryo...
8946973 - Azathioprine is useful in maintaining long-term remission induced by intravenous cyclos...
23582343 - An optimal combination for evar: low profile endograft body and continuous spiral stent...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Ginekologia polska     Volume:  83     ISSN:  0017-0011     ISO Abbreviation:  Ginekol. Pol.     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2013-03-15     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0374641     Medline TA:  Ginekol Pol     Country:  Poland    
Other Details:
Languages:  eng     Pagination:  910-5     Citation Subset:  IM    
Department of Obstetrics and Gynecology, Baskent University Faculty of Medicine, Konya, Turkey.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Prognostic factors in patients with primary invasive vaginal carcinoma.
Next Document:  [Assessment of uterine arteries Doppler in the first half of pregnancy in women with thrombophilia].